EBIT at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's EBIT?
- Rigel Pharmaceuticals (RIGL) reported EBIT of $11.89M in Q1 2026.
- How has Rigel Pharmaceuticals's EBIT changed year-over-year?
- Rigel Pharmaceuticals's EBIT decreased by 7.0% year-over-year, from $12.77M to $11.89M.
- What is the long-term trend for Rigel Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's EBIT has grown at a 78.0% compound annual growth rate (CAGR), from -$12.5M to $125.47M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.